R. Asinger

Publications140
h-index47
Citations13,816
Highly Influential Citations292
Claim Author Page
Author pages are created from data sourced from our academic publisher partnerships and public sources.

Recommended Authors

  • R. Hart
  • 441 Publications • 47,736 Citations
  • L. Pearce
  • 149 Publications • 18,206 Citations
  • J. Halperin
  • 616 Publications • 118,686 Citations
  • C. Herzog
  • 351 Publications • 26,220 Citations
  • Publications
  • Influence
ACC/AHA/ESC Guidelines for the Management of Patients With Atrial Fibrillation: Executive Summary A Report of the American College of Cardiology/American Heart Association Task Force on Practice…
View on PubMed
Cardiovascular disease in chronic kidney disease. A clinical update from Kidney Disease: Improving Global Outcomes (KDIGO).
TLDR
The current state of knowledge and the implications for patient care in important topic areas, including coronary artery disease and myocardial infarction, congestive heart failure, cerebrovascular disease, atrial fibrillation, peripheral arterial disease, and sudden cardiac death are defined.
View on PubMed
ST-segment elevation in conditions other than acute myocardial infarction.
TLDR
Many conditions other than acute myocardial infarction cause elevation of ST segments on an electrocardiogram and it is important to recognize and differentiate other causes of ST-segment elevation.
View on PubMed
Stroke with intermittent atrial fibrillation: incidence and predictors during aspirin therapy. Stroke Prevention in Atrial Fibrillation Investigators.
View on PubMed
Use of transesophageal echocardiography to guide cardioversion in patients with atrial fibrillation.
TLDR
The use of transesophageal echocardiography to guide the management of atrial fibrillation may be considered a clinically effective alternative strategy to conventional therapy for patients in whom elective cardioversion is planned.
View on PubMed
Factors associated with ischemic stroke during aspirin therapy in atrial fibrillation: analysis of 2012 participants in the SPAF I-III clinical trials. The Stroke Prevention in Atrial Fibrillation…
TLDR
Patients with AF who have high and low rates of stroke during treatment with aspirin can be identified and validation of the risk stratification scheme is necessary before it can be applied with confidence to clinical management.
View on PubMed
Transesophageal echocardiographic correlates of clinical risk of thromboembolism in nonvalvular atrial fibrillation. Stroke Prevention in Atrial Fibrillation III Investigators.
View on PubMed
Warfarin in atrial fibrillation patients with moderate chronic kidney disease.
TLDR
Adjusted-dose warfarin markedly reduced ischemic stroke/systemic embolism in high-risk atrial fibrillation patients with stage 3 CKD.
View on PubMed
Incidence of left-ventricular thrombosis after acute transmural myocardial infarction. Serial evaluation by two-dimensional echocardiography.
TLDR
It is concluded that patients with severe apical-wall-motion abnormalities during acute transmural anterior myocardial infarction are at high risk for left-ventricular thrombosis and this high-risk group can be identified before the development of left-volatile thrombi.
View on PubMed
Pathophysiologic correlates of thromboembolism in nonvalvular atrial fibrillation: I. Reduced flow velocity in the left atrial appendage (The Stroke Prevention in Atrial Fibrillation [SPAF-III]…
View on PubMed
...
...